Solving the dilemma of prevention of red cell alloimmunization

Immunotherapy

Volumn 4, Issue 9, 2012, Pages 903-905

  Branch, Donald R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

alloimmunization; hemolytic disease of the fetus and newborn; Kell; tolerogenic peptide

Indexed keywords

ALLOIMMUNIZATION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HELPER CELL; HEMATOPOIESIS; HEMOLYTIC ANEMIA; HUMAN; IN VITRO STUDY; NOTE; PRIORITY JOURNAL;

EID: 84867342863     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.12.90     Document Type: Note

References (17)

1. Daniels G, Poole J, deSilva M et al. The clinical significance of blood group antibodies. Transfus. Med. 12(5), 287-295 (2002). (Pubitemid 35178097)
2. Levine P, Pollack W. Hemolytic disease of the fetus and newborn. Med. Clin. North Am. 49(6), 1647-1660 (1965).
3. Kennedy MS. Perinatal issues in transfusion practice. In: Technical Manual (17th Edition). Roback JD (Ed.). American Association of Blood Banks, MD, USA, 631-643 (2008).
4. Duerbeck NB, Seeds JW. Rhesus immunization in pregnancy: a review. Obstet. Gynecol. Surv. 48(12), 801-810 (1993). (Pubitemid 23351122)
5. Gordon H. The diagnosis of hydrops fetalis. Clin. Obstet. Gynecol. 14(2), 548-560 (1971).
6. Machin GA. Hydrops revisited: literature review of 1414 cases published in the 1980s. Am. J. Med. Genet. 34(3), 366-390 (1989).
7. Freda VJ, Gorman JG, Pollack W. Suppression of the primary Rh immune response with passive Rh IgG immunoglobulin. N. Engl. J. Med. 277(19), 1022-1023 (1967).
8. Chown B, Bowman JM. Prevention of Rh immunization. Can. Med. Assoc. J. 100(6), 303-304 (1969).
9. Leggat HM, Gibson JM, Barron SL, Reid MM. Anti-Kell in pregnancy. Br. J. Obstet. Gynaecol. 98(2), 162-165 (1991).
10. Egbor M, Knott P, Bhide A. Red-cell and platelet alloimmunisation in pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 26(1), 119-132 (2012).
11. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus. Med. Rev. 21(1), 58-71 (2007). (Pubitemid 44881258)
12. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N. Engl. J. Med. 338(12), 798-803 (1998). (Pubitemid 28135986)
13. Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN. Identification, immunomodulatory activity and immunogenicity of the major helper T cell epitope on the K blood group antigen. Blood 119(23), 5563-5574 (2012).
14. Stott LM, Barker RN, Urbaniak SJ. Identification of alloreactive T-cell epitopes on the rhesus D protein. Blood 96(13), 4011-4019 (2000).
15. Marsh WL, Nichols ME, Oyen R et al. Naturally occurring anti-Kell stimulated by E. coli enterocolitis in a 20-day-old child. Transfusion 18(2), 149-154 (1978). (Pubitemid 8356265)
16. Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood 115(19), 3989-3996 (2010).
17. Hall AM, Cairns LS, Altmann DM, Barker RN, Urbaniak SJ. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 105(5), 2175-2179 (2005). (Pubitemid 40731810)